Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | The Biotech Growth Trust PLC (Ordinary Share) | -22.14% |
NAV | The Biotech Growth Trust PLC (Ordinary Share) | -20.89% |
Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | -- |
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Result of AGM
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
More ▼
Key statistics
On Friday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 808.00, 31.87% above the 52 week low of 612.70 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 25.37m |
---|---|
Market cap | 203.45m GBP |
Total assets | 237.68m GBP |
Total expense ratio | 1.12% |
High | 810.00 |
Low | 800.00 |
Previous close | 802.00 |
Average volume | 73.31k |
---|---|
YTD Change | -5.50% |
Beta | 0.4792 |
Diluted NAV (est) | 855.88 |
Diluted NAV (last pub) | 874.96 |
Premium/Discount | -6.25% |
Net Gearing | +6.79% |
Data delayed at least 20 minutes, as of Jul 18 2025 16:42 BST.
More ▼